The Ides of March Approach

George Yacik - INO.com Contributor - Fed & Interest Rates


In my previous post, I ended with the words, “Beware the Ides of March.” Well, if Janet Yellen and her friends on the Federal Reserve are to be believed, the Fed will raise interest rates on that day, and maybe several times after that later this year. Which leaves us with the uncomfortable thought of what happens to the bull market in stocks – and bonds, for that matter, too – that has been running virtually without interruption since the Fed dropped rates to zero back in 2008. Can the bulls continue to run without that prop?

If there were still any lingering doubts that the Fed would raise rates at its meeting next week, Yellen pretty much put those to rest in her speech in San Francisco last Friday. “At our meeting later this month, the [Fed’s monetary policy] committee will evaluate whether employment and inflation are continuing to evolve in line with our expectations, in which case a further adjustment of the federal funds rate would likely be appropriate,” Yellen said, adding that “the economy has essentially met the employment portion of our mandate and inflation is moving closer to our 2% objective.” That speech followed similar comments from several other Fed officials during the week. Continue reading "The Ides of March Approach"

Where Will OPEC's Cuts Affect Imports, Inventories?

Robert Boslego - INO.com Contributor - Energies


OPEC agreed to cut oil production by 1.164 million barrels per day beginning in January. Non-OPEC producers agreed to cut production around 560,000 b/d. The agreements were silent on exports.

Thus far, U.S. crude oil imports have been rising, despite the OPEC-non-OPEC cuts. In the year-to-date, net crude imports averaged 7.583 million barrels per day, up 2.7% v. the same period last year.

U.S. Net Crude Imports

U.S. crude imports from OPEC, in total, and Saudi Arabia, in particular, remain at high levels seven weeks into the cut. Crude imports from OPEC countries averaged 3.248 mmbd over the past 4 weeks, 14% higher than the same weeks last year. Continue reading "Where Will OPEC's Cuts Affect Imports, Inventories?"

Why Doesn't The Bond Market Trust The Fed?

George Yacik - INO.com Contributor - Fed & Interest Rates


The minutes of the Federal Reserve’s January 31-February 1 meeting released last week said we can expect another interest rate increase “fairly soon,” which many people think means at the March 14-15 meeting, just two weeks away. But the bond market doesn’t seem to be buying it. Why not?

According to the minutes, “many participants expressed the view that it might be appropriate to raise the federal funds rate again fairly soon if incoming information on the labor market and inflation was in line with or stronger than their current expectations or if the risks of overshooting the committee’s maximum-employment and inflation objectives increased.”

At her Congressional testimony a week earlier, Fed Chair Janet Yellen was even more hawkish, warning that “waiting too long to remove accommodation would be unwise, potentially requiring the FOMC to eventually raise rates rapidly, which could risk disrupting financial markets and pushing the economy into recession.” That doesn’t sound like someone who’s willing to wait until May, the Fed’s next monetary policy meeting after March (there’s no meeting in April). Continue reading "Why Doesn't The Bond Market Trust The Fed?"

Preview Issue #11: J&J $30B Acquisition, Humana/Aetna Blocked and Allergan Sued

INO Health & Biotech Stock Guide

Preview Issue #11 - February 28, 2017

BIOTECH, HEALTH & PHARMA NEWS

Johnson & Johnson and McKesson make a big splash in merger and acquisition activity, courts block Humana/Aetna merger and Allergan and Endo sued by FTC. The healthcare cohort has witnessed several key events in the face of a political backdrop that’s put the entire industry on edge. The overall healthcare umbrella has become sensitive to any tweet from President Trump as he vows to bring down drug prices. As he pursues his crusade against drug pricing, much of these threats may have already been priced-in as seen in many healthcare-related stocks (i.e. McKesson, CVS, ABBV and AGN) that have seen sharp and sustained sell-offs that coincide with the 2017 presidential campaign cycle.

WHAT'S NEXT

Continue reading "Preview Issue #11: J&J $30B Acquisition, Humana/Aetna Blocked and Allergan Sued"

Gold & Silver: Silver Has Ace In The Hole

Aibek Burabayev - INO.com Contributor - Metals


Everything in our world consists of uncountable invisible parts. It looks like a Great Constructor builds everything thoroughly copying and pasting the smallest parts of every single thing connecting it into something big and meaningful let it be living or non-living things.

And so are the market trends as they consist of the smallest tick trends, which are invisible on higher time frames. But when these ticks are built stable into one direction it makes a megatrend like the house is being built of small bricks. Top metals are now building an uptrend, which consists of smaller ones which I would like to highlight for you today in updated daily charts below. Continue reading "Gold & Silver: Silver Has Ace In The Hole"